+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atopic Dermatitis Market by Product (Light Therapy, Medication), Mode Of Administration (Oral Administration, Parenteral Administration, Topical Administration), Severity Level, Patient Demographics, Distribution Channel - Global Forecast 2025-2030- Product Image
Atopic Dermatitis Market by Product (Light Therapy, Medication), Mode Of Administration (Oral Administration, Parenteral Administration, Topical Administration), Severity Level, Patient Demographics, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Atopic Dermatitis Market by Product (Light Therapy, Medication), Mode Of Administration (Oral Administration, Parenteral Administration, Topical Administration), Severity Level, Patient Demographics, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977937
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The atopic dermatitis market is advancing rapidly, shaped by increased disease awareness, evolving therapeutic approaches, and the integration of digital health tools. Senior decision-makers must monitor shifts in patient needs, regulatory frameworks, and reimbursement models to maintain competitive advantage as this space continues to transform.

Market Snapshot: Atopic Dermatitis Market Growth and Outlook

The Atopic Dermatitis Market grew from USD 20.83 billion in 2024 to USD 22.02 billion in 2025. It is projected to continue expanding at a CAGR of 5.94%, with expectations to reach USD 29.45 billion by 2030. This growth reflects rising global prevalence across age groups and geographies, continued innovation in biologic and digital therapies, and intensified research and development focused on patient-centric care models.

Scope & Segmentation: In-Depth Analysis of Market Structure and Innovation Drivers

This research report provides a comprehensive breakdown of the atopic dermatitis sector, detailing critical sub-segments and geographical trends. Key elements include:

  • Product Types: Light therapy (including excimer laser, PUVA, and UVB modalities) and medication options such as antibiotics, antivirals, antifungals, antihistamines, corticosteroids, Janus Kinase (JAK) inhibitors, monoclonal antibodies, and calcineurin inhibitors.
  • Modes of Administration: Oral (capsules, tablets), parenteral (intramuscular, intravenous), and topical (cream, lotion, ointment) approaches, supporting customization for varied patient segments.
  • Severity Levels: Solutions tailored for mild, moderate, and severe atopic dermatitis to address escalating treatment complexity.
  • Patient Demographics: Distinct clinical considerations for both adult and pediatric patients, influencing dosing regimens and delivery preferences.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacies play complementary roles in maximized access and timely care delivery.
  • Regional Coverage: Extensive analysis of trends across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions, with strategic highlights for each sub-region and select major markets.
  • Key Market Participants: Evaluation of leading organizations including multinational pharmaceutical firms, biotechnology innovators, and specialized device manufacturers.

Key Takeaways: Strategic Insights for Decision-Makers

  • Demand for atopic dermatitis therapies is driven by both increasing prevalence and growing recognition of the disease’s burden, pushing healthcare providers toward adopting innovative treatments.
  • The market is seeing rapid integration of digital health platforms and precision therapies, supporting a transition from generalized to individualized patient care models.
  • Therapeutic portfolios are diversifying, with next-generation biologics and advanced light modalities expanding clinical choices, particularly in regions exhibiting strong clinical infrastructure.
  • Segmentation analysis reveals distinct needs and opportunities across patient age groups, severity levels, and preferences for therapy administration, suggesting tailored strategies are crucial for market success.
  • Industry partnerships between established pharmaceutical companies, biotechnology firms, and academic centers are accelerating the pace of research and ensuring faster time-to-market for promising treatments.

Impact of 2025 US Tariff Adjustments on Market Dynamics

Anticipated 2025 US tariff changes will influence supply chain costs and access to key atopic dermatitis therapeutics. Increased import duties on ingredients and phototherapy equipment may raise manufacturing and operational expenses. Manufacturers are expected to evaluate alternative sourcing and local production strategies, while payers and delivery networks might adjust formularies and support programs to mitigate potential access challenges. Senior leaders should prioritize supply chain resilience to ensure uninterrupted patient care.

Methodology & Data Sources

Report findings are built on a robust mix of primary and secondary research. Direct interviews with key opinion leaders and industry stakeholders informed qualitative analysis, while systematic review of peer-reviewed literature, regulatory documents, and company disclosures ensured comprehensive and reliable insight. Data triangulation and external expert validation were applied to enhance accuracy.

Why This Report Matters for Industry Leaders

  • Delivers actionable intelligence on innovation trends, regulatory shifts, and market entry strategies within a rapidly evolving therapeutic space.
  • Enables effective prioritization of pipeline investments, supply chain adaptations, and patient-centered initiatives by offering in-depth segmentation and regional insights.
  • Strengthens strategic planning by providing clarity on competitive positioning, partnership opportunities, and reimbursement models across diverse markets.

Conclusion

Senior leaders looking to succeed in the atopic dermatitis market need a clear understanding of shifting regulatory landscapes, technological advancements, and regional differences. This report provides essential insight to guide informed decision-making and sustained growth in a dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased adoption of Janus kinase inhibitors as first-line oral therapy in pediatric atopic dermatitis
5.2. Integration of digital health platforms for remote monitoring and management of atopic dermatitis flares
5.3. Surge in consumer demand for clean label, fragrance free topical emollients for sensitive atopic skin
5.4. Expansion of real world evidence studies demonstrating long-term safety of biologic treatments in atopic dermatitis
5.5. Growing investment in microbiome modulation therapies targeting chronic atopic dermatitis inflammation
5.6. Emergence of teledermatology networks improving specialist access for rural atopic dermatitis patients
5.7. Regulatory approvals driving global market entry of novel IL-4 and IL-13 receptor antagonists in dermatitis
5.8. Collaboration between pharmaceutical and cosmetic companies to create hybrid therapeutic skincare solutions for atopic dermatitis
5.9. Development of wearable sensor technology for continuous tracking of skin barrier integrity in dermatitis management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Atopic Dermatitis Market, by Product
8.1. Introduction
8.2. Light Therapy
8.2.1. Excimer Laser Therapy
8.2.2. PUVA Therapy
8.2.3. UVB Therapy
8.3. Medication
8.3.1. Antibiotics, Antivirals or Antifungals
8.3.2. Antihistamines
8.3.3. Corticosteroid
8.3.4. Janus Kinase (JAK) Inhibitors
8.3.5. Monoclonal Antibodies
8.3.6. Pimecrolimus or Tacrolimus
9. Atopic Dermatitis Market, by Mode Of Administration
9.1. Introduction
9.2. Oral Administration
9.2.1. Capsules
9.2.2. Tablets
9.3. Parenteral Administration
9.3.1. Intramuscular
9.3.2. Intravenous
9.4. Topical Administration
9.4.1. Cream
9.4.2. Lotion
9.4.3. Ointment
10. Atopic Dermatitis Market, by Severity Level
10.1. Introduction
10.2. Mild Atopic Dermatitis
10.3. Moderate Atopic Dermatitis
10.4. Severe Atopic Dermatitis
11. Atopic Dermatitis Market, by Patient Demographics
11.1. Introduction
11.2. Adult Patients
11.3. Pediatric Patients
12. Atopic Dermatitis Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Atopic Dermatitis Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Atopic Dermatitis Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Atopic Dermatitis Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Amgen Inc.
16.3.3. AstraZeneca PLC
16.3.4. Bausch Health Companies Inc.
16.3.5. Biofrontera AG
16.3.6. Bristol-Myers Squibb Company
16.3.7. Chugai Pharmaceutical Co., Ltd.
16.3.8. Daavlin Company
16.3.9. Eli Lilly and Company
16.3.10. F. Hoffmann-La Roche Ltd.
16.3.11. Galderma Holding SA
16.3.12. GlaxoSmithKline PLC
16.3.13. Incyte Corporation
16.3.14. Johnson & Johnson Services Inc.
16.3.15. LEO Pharma A/S
16.3.16. Maruho Co., Ltd
16.3.17. Novartis AG
16.3.18. Perrigo Company PLC
16.3.19. Pfizer, Inc.
16.3.20. Regeneron Pharmaceuticals, Inc
16.3.21. Sanofi SA
16.3.22. Solarc Systems Inc.
16.3.23. Teva Pharmaceutical Industries Ltd.
16.3.24. UCB S.A.
16.3.25. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ATOPIC DERMATITIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ATOPIC DERMATITIS MARKET: RESEARCHAI
FIGURE 26. ATOPIC DERMATITIS MARKET: RESEARCHSTATISTICS
FIGURE 27. ATOPIC DERMATITIS MARKET: RESEARCHCONTACTS
FIGURE 28. ATOPIC DERMATITIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ATOPIC DERMATITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ATOPIC DERMATITIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ATOPIC DERMATITIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY EXCIMER LASER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY EXCIMER LASER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PUVA THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PUVA THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY UVB THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY UVB THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIBIOTICS, ANTIVIRALS OR ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIBIOTICS, ANTIVIRALS OR ANTIFUNGALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY JANUS KINASE (JAK) INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY JANUS KINASE (JAK) INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PIMECROLIMUS OR TACROLIMUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PIMECROLIMUS OR TACROLIMUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LOTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY LOTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MILD ATOPIC DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MILD ATOPIC DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODERATE ATOPIC DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY MODERATE ATOPIC DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERE ATOPIC DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY SEVERE ATOPIC DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 132. CANADA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 133. CANADA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 134. CANADA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 135. CANADA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 136. CANADA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 137. CANADA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 142. CANADA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 143. CANADA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. CANADA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. CANADA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 147. CANADA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 148. CANADA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 149. CANADA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. CANADA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 152. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 254. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 255. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 256. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 257. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 258. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 259. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 268. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 269. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 270. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 271. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 274. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 275. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 276. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 277. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 278. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 279. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 284. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 285. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 288. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 289. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 290. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 291. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. ITALY ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 314. ITALY ATOPIC DERMATITIS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 315. ITALY ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2018-2024 (USD MILLION)
TABLE 316. ITALY ATOPIC DERMATITIS MARKET SIZE, BY LIGHT THERAPY, 2025-2030 (USD MILLION)
TABLE 317. ITALY ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2018-2024 (USD MILLION)
TABLE 318. ITALY ATOPIC DERMATITIS MARKET SIZE, BY MEDICATION, 2025-2030 (USD MILLION)
TABLE 319. ITALY ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. ITALY ATOPIC DERMATITIS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. ITALY ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. ITALY ATOPIC DERMATITIS MARKET SIZE, BY ORAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. ITALY ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 324. ITALY ATOPIC DERMATITIS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 325. ITALY ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 326. ITALY ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 327. ITALY ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2018-2024 (USD MILLION)
TABLE 328. ITALY ATOPIC DERMATITIS MARKET SIZE, BY SEVERITY LEVEL, 2025-2030 (USD MILLION)
TABLE 329. ITALY ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2024 (USD MILLION)
TABLE 330. ITALY ATOPIC DERMATITIS MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2025-2030 (USD MILLION)
TABLE 331. ITALY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 332. ITALY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHA

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Atopic Dermatitis market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Biofrontera AG
  • Bristol-Myers Squibb Company
  • Chugai Pharmaceutical Co., Ltd.
  • Daavlin Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Galderma Holding SA
  • GlaxoSmithKline PLC
  • Incyte Corporation
  • Johnson & Johnson Services Inc.
  • LEO Pharma A/S
  • Maruho Co., Ltd
  • Novartis AG
  • Perrigo Company PLC
  • Pfizer, Inc.
  • Regeneron Pharmaceuticals, Inc
  • Sanofi SA
  • Solarc Systems Inc.
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.02 Billion
Forecasted Market Value ( USD ) by 2030 $ 29.45 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Atopic Dermatitis Market Report and Forecast 2025-2034 - Product Image

Atopic Dermatitis Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From
Atopic Dermatitis Market Report 2025 - Product Image

Atopic Dermatitis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Severe Atopic Dermatitis Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Severe Atopic Dermatitis Market - A Global and Regional Analysis: Focus on Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Atopic Dermatitis Clinical Trials - Global Strategic Business Report - Product Image

Atopic Dermatitis Clinical Trials - Global Strategic Business Report

  • Report
  • 216 Pages
  • Global
From
Dermatology Market by Product Type (Diagnostic Devices, Phototherapy Devices, Systemic Therapies), Application (Acne, Atopic Dermatitis, Psoriasis), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Dermatology Market by Product Type (Diagnostic Devices, Phototherapy Devices, Systemic Therapies), Application (Acne, Atopic Dermatitis, Psoriasis), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.